You bring forward some very important considerations, some of which are beyond the mandate of the special access program.
On October 30th, 2018. See this statement in context.
On October 30th, 2018. See this statement in context.
October 30th, 2018 / 10:45 a.m.
Director General, Therapeutic Products Directorate, Department of Health
You bring forward some very important considerations, some of which are beyond the mandate of the special access program.
See context to find out what was said next.